Request for Covid-19 Impact Assessment of this Report
The United States Vial and Prefilled Syringe market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vial and Prefilled Syringe market, reaching US$ million by the year 2028. As for the Europe Vial and Prefilled Syringe landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vial and Prefilled Syringe players cover BD (US), Gerresheimer (DE), Nipro Corporation (JP), and Schott forma vitrum (DE), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vial and Prefilled Syringe market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Glass Vial and Prefilled Syringe
Polymer Vial and Prefilled Syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Antithrombotics
Vaccines
Autoimmune Diseases
Anti-inflammatory Drugs
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BD (US)
Gerresheimer (DE)
Nipro Corporation (JP)
Schott forma vitrum (DE)
Ompi (IT)
Baxter BioPharma Solution (US)
ROVI CM (ES)
Terumo (JP)
Vetter (DE)
Unilife Corporation (US)
Taisei Kako (JP)
Roselabs Group (IN)
ARTE CORPORATION (JP)
Weigao Group Medical Polymer (CN)
Zibo Minkang Pharmaceutical (CN)
Shandong Pharmaceutical Glass (CN)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vial and Prefilled Syringe Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vial and Prefilled Syringe by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vial and Prefilled Syringe by Country/Region, 2017, 2022 & 2028
2.2 Vial and Prefilled Syringe Segment by Type
2.2.1 Glass Vial and Prefilled Syringe
2.2.2 Polymer Vial and Prefilled Syringe
2.3 Vial and Prefilled Syringe Sales by Type
2.3.1 Global Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
2.3.2 Global Vial and Prefilled Syringe Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vial and Prefilled Syringe Sale Price by Type (2017-2022)
2.4 Vial and Prefilled Syringe Segment by Application
2.4.1 Antithrombotics
2.4.2 Vaccines
2.4.3 Autoimmune Diseases
2.4.4 Anti-inflammatory Drugs
2.4.5 Others
2.5 Vial and Prefilled Syringe Sales by Application
2.5.1 Global Vial and Prefilled Syringe Sale Market Share by Application (2017-2022)
2.5.2 Global Vial and Prefilled Syringe Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vial and Prefilled Syringe Sale Price by Application (2017-2022)
3 Global Vial and Prefilled Syringe by Company
3.1 Global Vial and Prefilled Syringe Breakdown Data by Company
3.1.1 Global Vial and Prefilled Syringe Annual Sales by Company (2020-2022)
3.1.2 Global Vial and Prefilled Syringe Sales Market Share by Company (2020-2022)
3.2 Global Vial and Prefilled Syringe Annual Revenue by Company (2020-2022)
3.2.1 Global Vial and Prefilled Syringe Revenue by Company (2020-2022)
3.2.2 Global Vial and Prefilled Syringe Revenue Market Share by Company (2020-2022)
3.3 Global Vial and Prefilled Syringe Sale Price by Company
3.4 Key Manufacturers Vial and Prefilled Syringe Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vial and Prefilled Syringe Product Location Distribution
3.4.2 Players Vial and Prefilled Syringe Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vial and Prefilled Syringe by Geographic Region
4.1 World Historic Vial and Prefilled Syringe Market Size by Geographic Region (2017-2022)
4.1.1 Global Vial and Prefilled Syringe Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vial and Prefilled Syringe Annual Revenue by Geographic Region
4.2 World Historic Vial and Prefilled Syringe Market Size by Country/Region (2017-2022)
4.2.1 Global Vial and Prefilled Syringe Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vial and Prefilled Syringe Annual Revenue by Country/Region
4.3 Americas Vial and Prefilled Syringe Sales Growth
4.4 APAC Vial and Prefilled Syringe Sales Growth
4.5 Europe Vial and Prefilled Syringe Sales Growth
4.6 Middle East & Africa Vial and Prefilled Syringe Sales Growth
5 Americas
5.1 Americas Vial and Prefilled Syringe Sales by Country
5.1.1 Americas Vial and Prefilled Syringe Sales by Country (2017-2022)
5.1.2 Americas Vial and Prefilled Syringe Revenue by Country (2017-2022)
5.2 Americas Vial and Prefilled Syringe Sales by Type
5.3 Americas Vial and Prefilled Syringe Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vial and Prefilled Syringe Sales by Region
6.1.1 APAC Vial and Prefilled Syringe Sales by Region (2017-2022)
6.1.2 APAC Vial and Prefilled Syringe Revenue by Region (2017-2022)
6.2 APAC Vial and Prefilled Syringe Sales by Type
6.3 APAC Vial and Prefilled Syringe Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vial and Prefilled Syringe by Country
7.1.1 Europe Vial and Prefilled Syringe Sales by Country (2017-2022)
7.1.2 Europe Vial and Prefilled Syringe Revenue by Country (2017-2022)
7.2 Europe Vial and Prefilled Syringe Sales by Type
7.3 Europe Vial and Prefilled Syringe Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vial and Prefilled Syringe by Country
8.1.1 Middle East & Africa Vial and Prefilled Syringe Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vial and Prefilled Syringe Revenue by Country (2017-2022)
8.2 Middle East & Africa Vial and Prefilled Syringe Sales by Type
8.3 Middle East & Africa Vial and Prefilled Syringe Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vial and Prefilled Syringe
10.3 Manufacturing Process Analysis of Vial and Prefilled Syringe
10.4 Industry Chain Structure of Vial and Prefilled Syringe
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vial and Prefilled Syringe Distributors
11.3 Vial and Prefilled Syringe Customer
12 World Forecast Review for Vial and Prefilled Syringe by Geographic Region
12.1 Global Vial and Prefilled Syringe Market Size Forecast by Region
12.1.1 Global Vial and Prefilled Syringe Forecast by Region (2023-2028)
12.1.2 Global Vial and Prefilled Syringe Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vial and Prefilled Syringe Forecast by Type
12.7 Global Vial and Prefilled Syringe Forecast by Application
13 Key Players Analysis
13.1 BD (US)
13.1.1 BD (US) Company Information
13.1.2 BD (US) Vial and Prefilled Syringe Product Offered
13.1.3 BD (US) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BD (US) Main Business Overview
13.1.5 BD (US) Latest Developments
13.2 Gerresheimer (DE)
13.2.1 Gerresheimer (DE) Company Information
13.2.2 Gerresheimer (DE) Vial and Prefilled Syringe Product Offered
13.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Gerresheimer (DE) Main Business Overview
13.2.5 Gerresheimer (DE) Latest Developments
13.3 Nipro Corporation (JP)
13.3.1 Nipro Corporation (JP) Company Information
13.3.2 Nipro Corporation (JP) Vial and Prefilled Syringe Product Offered
13.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nipro Corporation (JP) Main Business Overview
13.3.5 Nipro Corporation (JP) Latest Developments
13.4 Schott forma vitrum (DE)
13.4.1 Schott forma vitrum (DE) Company Information
13.4.2 Schott forma vitrum (DE) Vial and Prefilled Syringe Product Offered
13.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Schott forma vitrum (DE) Main Business Overview
13.4.5 Schott forma vitrum (DE) Latest Developments
13.5 Ompi (IT)
13.5.1 Ompi (IT) Company Information
13.5.2 Ompi (IT) Vial and Prefilled Syringe Product Offered
13.5.3 Ompi (IT) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ompi (IT) Main Business Overview
13.5.5 Ompi (IT) Latest Developments
13.6 Baxter BioPharma Solution (US)
13.6.1 Baxter BioPharma Solution (US) Company Information
13.6.2 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Offered
13.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Baxter BioPharma Solution (US) Main Business Overview
13.6.5 Baxter BioPharma Solution (US) Latest Developments
13.7 ROVI CM (ES)
13.7.1 ROVI CM (ES) Company Information
13.7.2 ROVI CM (ES) Vial and Prefilled Syringe Product Offered
13.7.3 ROVI CM (ES) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 ROVI CM (ES) Main Business Overview
13.7.5 ROVI CM (ES) Latest Developments
13.8 Terumo (JP)
13.8.1 Terumo (JP) Company Information
13.8.2 Terumo (JP) Vial and Prefilled Syringe Product Offered
13.8.3 Terumo (JP) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Terumo (JP) Main Business Overview
13.8.5 Terumo (JP) Latest Developments
13.9 Vetter (DE)
13.9.1 Vetter (DE) Company Information
13.9.2 Vetter (DE) Vial and Prefilled Syringe Product Offered
13.9.3 Vetter (DE) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vetter (DE) Main Business Overview
13.9.5 Vetter (DE) Latest Developments
13.10 Unilife Corporation (US)
13.10.1 Unilife Corporation (US) Company Information
13.10.2 Unilife Corporation (US) Vial and Prefilled Syringe Product Offered
13.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Unilife Corporation (US) Main Business Overview
13.10.5 Unilife Corporation (US) Latest Developments
13.11 Taisei Kako (JP)
13.11.1 Taisei Kako (JP) Company Information
13.11.2 Taisei Kako (JP) Vial and Prefilled Syringe Product Offered
13.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Taisei Kako (JP) Main Business Overview
13.11.5 Taisei Kako (JP) Latest Developments
13.12 Roselabs Group (IN)
13.12.1 Roselabs Group (IN) Company Information
13.12.2 Roselabs Group (IN) Vial and Prefilled Syringe Product Offered
13.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Roselabs Group (IN) Main Business Overview
13.12.5 Roselabs Group (IN) Latest Developments
13.13 ARTE CORPORATION (JP)
13.13.1 ARTE CORPORATION (JP) Company Information
13.13.2 ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Offered
13.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ARTE CORPORATION (JP) Main Business Overview
13.13.5 ARTE CORPORATION (JP) Latest Developments
13.14 Weigao Group Medical Polymer (CN)
13.14.1 Weigao Group Medical Polymer (CN) Company Information
13.14.2 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Offered
13.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Weigao Group Medical Polymer (CN) Main Business Overview
13.14.5 Weigao Group Medical Polymer (CN) Latest Developments
13.15 Zibo Minkang Pharmaceutical (CN)
13.15.1 Zibo Minkang Pharmaceutical (CN) Company Information
13.15.2 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Offered
13.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Zibo Minkang Pharmaceutical (CN) Main Business Overview
13.15.5 Zibo Minkang Pharmaceutical (CN) Latest Developments
13.16 Shandong Pharmaceutical Glass (CN)
13.16.1 Shandong Pharmaceutical Glass (CN) Company Information
13.16.2 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Offered
13.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shandong Pharmaceutical Glass (CN) Main Business Overview
13.16.5 Shandong Pharmaceutical Glass (CN) Latest Developments
14 Research Findings and Conclusion
Table 1. Vial and Prefilled Syringe Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vial and Prefilled Syringe Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Glass Vial and Prefilled Syringe
Table 4. Major Players of Polymer Vial and Prefilled Syringe
Table 5. Global Vial and Prefilled Syringe Sales by Type (2017-2022) & (K Units)
Table 6. Global Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
Table 7. Global Vial and Prefilled Syringe Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vial and Prefilled Syringe Revenue Market Share by Type (2017-2022)
Table 9. Global Vial and Prefilled Syringe Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Vial and Prefilled Syringe Sales by Application (2017-2022) & (K Units)
Table 11. Global Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Table 12. Global Vial and Prefilled Syringe Revenue by Application (2017-2022)
Table 13. Global Vial and Prefilled Syringe Revenue Market Share by Application (2017-2022)
Table 14. Global Vial and Prefilled Syringe Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Vial and Prefilled Syringe Sales by Company (2020-2022) & (K Units)
Table 16. Global Vial and Prefilled Syringe Sales Market Share by Company (2020-2022)
Table 17. Global Vial and Prefilled Syringe Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vial and Prefilled Syringe Revenue Market Share by Company (2020-2022)
Table 19. Global Vial and Prefilled Syringe Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Vial and Prefilled Syringe Producing Area Distribution and Sales Area
Table 21. Players Vial and Prefilled Syringe Products Offered
Table 22. Vial and Prefilled Syringe Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vial and Prefilled Syringe Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Vial and Prefilled Syringe Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vial and Prefilled Syringe Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vial and Prefilled Syringe Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vial and Prefilled Syringe Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Vial and Prefilled Syringe Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vial and Prefilled Syringe Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vial and Prefilled Syringe Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vial and Prefilled Syringe Sales by Country (2017-2022) & (K Units)
Table 34. Americas Vial and Prefilled Syringe Sales Market Share by Country (2017-2022)
Table 35. Americas Vial and Prefilled Syringe Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vial and Prefilled Syringe Revenue Market Share by Country (2017-2022)
Table 37. Americas Vial and Prefilled Syringe Sales by Type (2017-2022) & (K Units)
Table 38. Americas Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
Table 39. Americas Vial and Prefilled Syringe Sales by Application (2017-2022) & (K Units)
Table 40. Americas Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Table 41. APAC Vial and Prefilled Syringe Sales by Region (2017-2022) & (K Units)
Table 42. APAC Vial and Prefilled Syringe Sales Market Share by Region (2017-2022)
Table 43. APAC Vial and Prefilled Syringe Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vial and Prefilled Syringe Revenue Market Share by Region (2017-2022)
Table 45. APAC Vial and Prefilled Syringe Sales by Type (2017-2022) & (K Units)
Table 46. APAC Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
Table 47. APAC Vial and Prefilled Syringe Sales by Application (2017-2022) & (K Units)
Table 48. APAC Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Table 49. Europe Vial and Prefilled Syringe Sales by Country (2017-2022) & (K Units)
Table 50. Europe Vial and Prefilled Syringe Sales Market Share by Country (2017-2022)
Table 51. Europe Vial and Prefilled Syringe Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vial and Prefilled Syringe Revenue Market Share by Country (2017-2022)
Table 53. Europe Vial and Prefilled Syringe Sales by Type (2017-2022) & (K Units)
Table 54. Europe Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
Table 55. Europe Vial and Prefilled Syringe Sales by Application (2017-2022) & (K Units)
Table 56. Europe Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vial and Prefilled Syringe Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Vial and Prefilled Syringe Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vial and Prefilled Syringe Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vial and Prefilled Syringe Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vial and Prefilled Syringe Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Vial and Prefilled Syringe Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vial and Prefilled Syringe Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vial and Prefilled Syringe
Table 66. Key Market Challenges & Risks of Vial and Prefilled Syringe
Table 67. Key Industry Trends of Vial and Prefilled Syringe
Table 68. Vial and Prefilled Syringe Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vial and Prefilled Syringe Distributors List
Table 71. Vial and Prefilled Syringe Customer List
Table 72. Global Vial and Prefilled Syringe Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Vial and Prefilled Syringe Sales Market Forecast by Region
Table 74. Global Vial and Prefilled Syringe Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vial and Prefilled Syringe Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vial and Prefilled Syringe Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Vial and Prefilled Syringe Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vial and Prefilled Syringe Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Vial and Prefilled Syringe Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vial and Prefilled Syringe Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Vial and Prefilled Syringe Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vial and Prefilled Syringe Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Vial and Prefilled Syringe Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vial and Prefilled Syringe Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Vial and Prefilled Syringe Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vial and Prefilled Syringe Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vial and Prefilled Syringe Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vial and Prefilled Syringe Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Vial and Prefilled Syringe Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vial and Prefilled Syringe Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vial and Prefilled Syringe Revenue Market Share Forecast by Application (2023-2028)
Table 92. BD (US) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 93. BD (US) Vial and Prefilled Syringe Product Offered
Table 94. BD (US) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. BD (US) Main Business
Table 96. BD (US) Latest Developments
Table 97. Gerresheimer (DE) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 98. Gerresheimer (DE) Vial and Prefilled Syringe Product Offered
Table 99. Gerresheimer (DE) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Gerresheimer (DE) Main Business
Table 101. Gerresheimer (DE) Latest Developments
Table 102. Nipro Corporation (JP) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 103. Nipro Corporation (JP) Vial and Prefilled Syringe Product Offered
Table 104. Nipro Corporation (JP) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Nipro Corporation (JP) Main Business
Table 106. Nipro Corporation (JP) Latest Developments
Table 107. Schott forma vitrum (DE) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 108. Schott forma vitrum (DE) Vial and Prefilled Syringe Product Offered
Table 109. Schott forma vitrum (DE) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Schott forma vitrum (DE) Main Business
Table 111. Schott forma vitrum (DE) Latest Developments
Table 112. Ompi (IT) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 113. Ompi (IT) Vial and Prefilled Syringe Product Offered
Table 114. Ompi (IT) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Ompi (IT) Main Business
Table 116. Ompi (IT) Latest Developments
Table 117. Baxter BioPharma Solution (US) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 118. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Offered
Table 119. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Baxter BioPharma Solution (US) Main Business
Table 121. Baxter BioPharma Solution (US) Latest Developments
Table 122. ROVI CM (ES) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 123. ROVI CM (ES) Vial and Prefilled Syringe Product Offered
Table 124. ROVI CM (ES) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. ROVI CM (ES) Main Business
Table 126. ROVI CM (ES) Latest Developments
Table 127. Terumo (JP) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 128. Terumo (JP) Vial and Prefilled Syringe Product Offered
Table 129. Terumo (JP) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Terumo (JP) Main Business
Table 131. Terumo (JP) Latest Developments
Table 132. Vetter (DE) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 133. Vetter (DE) Vial and Prefilled Syringe Product Offered
Table 134. Vetter (DE) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Vetter (DE) Main Business
Table 136. Vetter (DE) Latest Developments
Table 137. Unilife Corporation (US) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 138. Unilife Corporation (US) Vial and Prefilled Syringe Product Offered
Table 139. Unilife Corporation (US) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Unilife Corporation (US) Main Business
Table 141. Unilife Corporation (US) Latest Developments
Table 142. Taisei Kako (JP) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 143. Taisei Kako (JP) Vial and Prefilled Syringe Product Offered
Table 144. Taisei Kako (JP) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Taisei Kako (JP) Main Business
Table 146. Taisei Kako (JP) Latest Developments
Table 147. Roselabs Group (IN) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 148. Roselabs Group (IN) Vial and Prefilled Syringe Product Offered
Table 149. Roselabs Group (IN) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Roselabs Group (IN) Main Business
Table 151. Roselabs Group (IN) Latest Developments
Table 152. ARTE CORPORATION (JP) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 153. ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Offered
Table 154. ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. ARTE CORPORATION (JP) Main Business
Table 156. ARTE CORPORATION (JP) Latest Developments
Table 157. Weigao Group Medical Polymer (CN) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 158. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Offered
Table 159. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Weigao Group Medical Polymer (CN) Main Business
Table 161. Weigao Group Medical Polymer (CN) Latest Developments
Table 162. Zibo Minkang Pharmaceutical (CN) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 163. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Offered
Table 164. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Zibo Minkang Pharmaceutical (CN) Main Business
Table 166. Zibo Minkang Pharmaceutical (CN) Latest Developments
Table 167. Shandong Pharmaceutical Glass (CN) Basic Information, Vial and Prefilled Syringe Manufacturing Base, Sales Area and Its Competitors
Table 168. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Offered
Table 169. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Shandong Pharmaceutical Glass (CN) Main Business
Table 171. Shandong Pharmaceutical Glass (CN) Latest Developments
List of Figures
Figure 1. Picture of Vial and Prefilled Syringe
Figure 2. Vial and Prefilled Syringe Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vial and Prefilled Syringe Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Vial and Prefilled Syringe Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vial and Prefilled Syringe Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Glass Vial and Prefilled Syringe
Figure 10. Product Picture of Polymer Vial and Prefilled Syringe
Figure 11. Global Vial and Prefilled Syringe Sales Market Share by Type in 2021
Figure 12. Global Vial and Prefilled Syringe Revenue Market Share by Type (2017-2022)
Figure 13. Vial and Prefilled Syringe Consumed in Antithrombotics
Figure 14. Global Vial and Prefilled Syringe Market: Antithrombotics (2017-2022) & (K Units)
Figure 15. Vial and Prefilled Syringe Consumed in Vaccines
Figure 16. Global Vial and Prefilled Syringe Market: Vaccines (2017-2022) & (K Units)
Figure 17. Vial and Prefilled Syringe Consumed in Autoimmune Diseases
Figure 18. Global Vial and Prefilled Syringe Market: Autoimmune Diseases (2017-2022) & (K Units)
Figure 19. Vial and Prefilled Syringe Consumed in Anti-inflammatory Drugs
Figure 20. Global Vial and Prefilled Syringe Market: Anti-inflammatory Drugs (2017-2022) & (K Units)
Figure 21. Vial and Prefilled Syringe Consumed in Others
Figure 22. Global Vial and Prefilled Syringe Market: Others (2017-2022) & (K Units)
Figure 23. Global Vial and Prefilled Syringe Sales Market Share by Application (2017-2022)
Figure 24. Global Vial and Prefilled Syringe Revenue Market Share by Application in 2021
Figure 25. Vial and Prefilled Syringe Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Vial and Prefilled Syringe Revenue Market Share by Company in 2021
Figure 27. Global Vial and Prefilled Syringe Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Vial and Prefilled Syringe Revenue Market Share by Geographic Region in 2021
Figure 29. Global Vial and Prefilled Syringe Sales Market Share by Region (2017-2022)
Figure 30. Global Vial and Prefilled Syringe Revenue Market Share by Country/Region in 2021
Figure 31. Americas Vial and Prefilled Syringe Sales 2017-2022 (K Units)
Figure 32. Americas Vial and Prefilled Syringe Revenue 2017-2022 ($ Millions)
Figure 33. APAC Vial and Prefilled Syringe Sales 2017-2022 (K Units)
Figure 34. APAC Vial and Prefilled Syringe Revenue 2017-2022 ($ Millions)
Figure 35. Europe Vial and Prefilled Syringe Sales 2017-2022 (K Units)
Figure 36. Europe Vial and Prefilled Syringe Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Vial and Prefilled Syringe Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Vial and Prefilled Syringe Revenue 2017-2022 ($ Millions)
Figure 39. Americas Vial and Prefilled Syringe Sales Market Share by Country in 2021
Figure 40. Americas Vial and Prefilled Syringe Revenue Market Share by Country in 2021
Figure 41. United States Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Vial and Prefilled Syringe Sales Market Share by Region in 2021
Figure 46. APAC Vial and Prefilled Syringe Revenue Market Share by Regions in 2021
Figure 47. China Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Vial and Prefilled Syringe Sales Market Share by Country in 2021
Figure 54. Europe Vial and Prefilled Syringe Revenue Market Share by Country in 2021
Figure 55. Germany Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Vial and Prefilled Syringe Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Vial and Prefilled Syringe Revenue Market Share by Country in 2021
Figure 62. Egypt Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Vial and Prefilled Syringe Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Vial and Prefilled Syringe in 2021
Figure 68. Manufacturing Process Analysis of Vial and Prefilled Syringe
Figure 69. Industry Chain Structure of Vial and Prefilled Syringe
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...